Maili Model Featured Image 1 (1)

A New Opportunity

Through identifying a sizeable gap in the market for fillers to maximise volume, suppleness and longevity combined, MaiLi utilised a unique opportunity to design a premium line of HA gels to meet this demand.

Model is not an actual patient.
After my treatment with MaiLi, I felt it gave my appearance a boost. The natural looking results are amazing.

MaiLi’s Projection Force Was Tested Against Competitors

An Unstoppable Portfolio

Reverse the Signs of Ageing



Craft your cosmetic vision with a premium gel offering supple volume, projection power and elasticity – reflecting natural movement for authentic beauty.



Treat areas with more fullness from less filler*, resulting in long-lasting satisfaction, that may bring positive reviews and repeat bookings.

*Clinical investigation 17E1176: in comparison to Juvederm® Voluma, 24% less product of MaiLi Extreme was injected for the same results in the treatment of the cheek area.



MaiLi’s cutting-edge science creates durable gels with market-leading results – including supple, full lips lasting up to a year.**

**Data on file. GAIS, Global Aesthetic Improvement Scale.



MaiLi has a good safety profile, which is why all products are developed with the utmost care, while using lidocaine for a more comfortable experience.

Contact Us

If you have any questions about Maili or related treatment please ask us here.
I am interested in

*Clinical investigation 17E1176: in comparison to Juveìderm® Voluma, 24% less product of MaiLi Extreme was injected for the same results in the treatment of the cheek area.

***Data on file. Group 4 in the clinical trial17E1176: 40 injections sites in 20 patients. GAIS, global aesthetic improvement scale

*** Data on file. GAIS, Global Aesthetic Improvement Scale.


CE 2797: MaiLi devices are intended for the correction of facial wrinkles or folds, for the definition or enhancement of the lips, and for the restoration or enhancement of facial volume. MaiLi is also indicated for scar tissue treatment and volume lost by HIV-associated lipoatrophy.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised MaiLi distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings and precautions for this product please refer to the Product Instructions for Use.